Salix Pharmaceuticals Newswire

Comprehensive Real-Time News Feed for Salix Pharmaceuticals.

Results 1 - 20 of 1,007 in Salix Pharmaceuticals

  1. Progenics trading halted, pending newsRead the original story

    55 min ago | Theflyonthewall.com

    FDA says RELISTOR can be approved on data submitted in sNDA Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration has informed Salix that RELISTOR can be approved on the data submitted in the sNDA.

    Comment?

  2. Companies take US benefits, but flee US taxesRead the original story w/Photo

    1 hr ago | Myrtle Beach Online

    ... paper and handing their tax burden to American taxpayers. The latest to seek refuge from Uncle Sam is Salix Pharmaceuticals of Raleigh. The company announced last week that it is merging with an Italian drug company and will re-incorporate in ...

    Comment?

  3. FDA Office of Drug Evaluation III Approves Salix's Request that the...Read the original story

    1 hr ago | Investor's Business Daily

    Post-marketing Observations Cohort Study Required to Assess Relative Incidence of MACE in Patients using RELISTOR Subcutaneous Injection Compared to Patients Using Other Comparator Treatments for Opioid-induced Constipation RALEIGH, N.C. & TARRYTOWN, N.Y.-- -- Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals today announced that the Food ... (more)

    Comment?

  4. FDA Office of Drug Evaluation III Approves Salix's Request that the ...Read the original story

    1 hr ago | Business Wire

    ... Treatments for Opioid-induced Constipation RALEIGH, N.C. & TARRYTOWN, N.Y.--( BUSINESS WIRE )--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today announced that the Food and Drug Administration (FDA or ...

    Comment?

  5. Progenics Holds Conference Call This Morning on FDA Appeal Response...Read the original story

    2 hrs ago | GlobeNewswire

    ... is available in the joint press release issued this morning with the Company's collaboration partner, Salix Pharmaceuticals (Nasdaq: SLXP ). To participate in the call, please dial (877) 250-8889 (domestic) or (720) 545-0001 (international) and ...

    Comment?

  6. FDA says RELISTOR can be approved on data submitted in sNDARead the original story

    Monday Jun 30 | Theflyonthewall.com

    ... JMP Securities keeps an Outperform rating on the stock. Salix to combine with Cosmo Technologies Salix Pharmaceuticals and Cosmo Pharmaceuticals announced a definitive merger agreement under which Salix will combine with Cosmo Technologies, a ...

    Comment?

  7. Stocks end week lower on European, Fed concernsRead the original story w/Photo

    Friday Jun 27 | Theflyonthewall.com

    ... the last two weeks. Salix announces outcome for TARGET 3 study evaluating rifaximin Salix Pharmaceuticals announced the "successful" outcome of TARGET 3, a Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and ...

    Comment?

  8. Salix Pharmaceuticals Given New $155.00 Price Target at Stifel NicolausRead the original story

    Thursday Jul 10 | AmericanBankingNews.com

    ... target price suggests a potential upside of 15.81% from the company's current price. In other Salix Pharmaceuticals news, CEO Carolyn J. Logan unloaded 53,057 shares of the stock in a transaction that occurred on Thursday, June 26th. The shares were ...

    Comment?

  9. Cosmo Rejected Salix Complete Takeover Approach, Cosmo CEO SaysRead the original story

    Thursday Jul 10 | The Washington Post

    Salix Pharmaceuticals Ltd., the drugmaker buying patents from Cosmo Pharmaceuticals SpA in a deal that will allow it to move from the U.S., initially proposed buying the Italian company outright.

    Comment?

  10. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Jul 10 | Business Wire

    The new issue report is available at 'www.fitchratings.com' or by clicking on the link above.

    Comment?

  11. Salix Shareholder Alert: Former Sec Attorney Willie Briscoe and...Read the original story

    Thursday Jul 10 | Business Wire

    Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Salix Pharmaceuticals, Ltd. concerning the merger with Cosmo Tech, a subsidiary of Cosmo Pharmaceuticals.

    Comment?

  12. Will This Price Target Increase Help Salix Pharmaceuticals (SLXP) Stock Today?Read the original story w/Photo

    Thursday Jul 10 | TheStreet.com

    ... on sales and IBS data according to UBS analyst Marc Goodman. Separately, TheStreet Ratings team rates SALIX PHARMACEUTICALS LTD as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation: "We rate SALIX ...

    Comment?

  13. Salix price target raised to $192 from $126 at Piper JaffrayRead the original story

    Friday Jun 27 | Theflyonthewall.com

    ... JMP Securities keeps an Outperform rating on the stock. Salix to combine with Cosmo Technologies Salix Pharmaceuticals and Cosmo Pharmaceuticals announced a definitive merger agreement under which Salix will combine with Cosmo Technologies, a ...

    Comment?

  14. Cadwalader Takes Corporate Inversions to Another LevelRead the original story w/Photo

    Wednesday Jul 9 | Law.com

    ... way to help more U.S. companies use the controversial maneuver to lower their tax bills. Raleigh-based Salix Pharmaceuticals has retained Cadwalader, as well as Covington & Burling and leading Irish firm A&L Goodbody, for its $2.7 billion all-stock ...

    Comment?

  15. Salix Pharmaceuticals: - Better Deal Than It Is Being Viewed'Read the original story

    Wednesday Jul 9 | Barron's

    On July 1, Salix Pharmaceuticals jumped 14% after announcing positive results from a drug trial .

    Comment?

  16. Salix to Move to Ireland in $2.7 Billion Cosmo Tax InversionRead the original story

    Wednesday Jul 9 | The Washington Post

    Salix Pharmaceuticals Ltd. agreed to buy patents to three gastrointestinal drugs from Cosmo Pharmaceuticals SpA for about $2.7 billion in stock, allowing the U.S. company to move to Ireland and lower its tax bill.

    Comment?

  17. Shareholder Alert: Brower Piven Announces The Investigation Of Salix...Read the original story

    Wednesday Jul 9 | Customer Interaction Solutions

    The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the board of directors of Salix Pharmaceuticals, Ltd. relating to the proposed buyout of the Company.

    Comment?

  18. The Salix deal boils down to tax savings and drug rightsRead the original story w/Photo

    Wednesday Jul 9 | Business Journal

    Adam Derbyshire, Chief Financial Officer and Executive Vice President of Finance & Administration for Salix Pharmaceuticals, says the deal with Cosmo Technologies will bring tax savings.

    Comment?

  19. Irish-based M&A surges on back of U.S. companies' tax inversion dealsRead the original story

    Wednesday Jul 9 | Reuters

    ... and Swiss-listed Cosmo Pharmaceuticals said on Wednesday that it would merge its Irish subsidiary with Salix Pharmaceuticals. We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that ...

    Comment?

  20. US stocks finish higher on Alcoa earnings, Fed minutesRead the original story w/Photo

    Wednesday Jul 9 | Channelnewsasia.com

    ... we are experiencing a retail 'funk,'" said Kip Tindell, chief executive of the Container Store. Salix Pharmaceuticals announced it reached a deal to combine with an Irish-based subsidiary of Cosmo Pharmaceuticals of Italy. The companies said the ...

    Comment?